Biologics & Biosimilars Symposium: Key Considerations & Strategies in Early Stage Development 2015

This complimentary Scientific Symposium is designed for the New England Pharmaceutical and Biopharmaceutical communities. The goal for this meeting is to create a forum for the exchange of ideas on manufacturing, drug development and biomedical research. The Symposium (16:30 – 18:40 | October 16th, 2014) will include presentations from industry experts on early phase drug development covering discovery, clinical and bioanalytical perspectives.
Topics covered will include:
Making Partnerships Work: Pharma, Biotech, CRO
Bryan Tayefeh, Senior Manager of Alliance Management and Corporate Development, Isis Pharmaceuticals
Enabling Rapid Biologics Development and Manufacturing
Haodi Dong, Technical Director, WuXi Biologics
The Biopharma Perspective: Design and Evaluation of First in Man and Complex Patient Trials with Biologics
Ryan Iarrobino, Senior Director of Clinical Development, Dyax Corp
Clinical Pharmacology Site Perspective: Evaluation of Protocol Design, Recruiting Concerns and Safety Measures in First in Man and Complex Patient Trials with Biologics
Lorraine M. Rusch, Ph.D., Vice President, Business Development, Vince and Associates Clinical Research